Haemonetics (HAE) in our Pivotal Point Check: Return of Major Customer and Q1 Figures Trigger a 16% Share Price Jump in Medical Technology Stock!

Comeback with a major customer: CSL Plasma will now use the NexSys-PCS devices with Persona-PLUS technology in the USA. Validation of the platform: The return of the previously lost customer underscores Haemonetics' technological strength. Strong financial foundation: Convincing Q1 results and an increased annual forecast provided momentum in advance. Haemonetics, a provider of medical technology and systems for blood and plasma management, caused a significant stock jump with high volume on August 18. The stock rose nearly 16%...